Dr Konstantinos Tselios, MD, PhD - Toronto Western Hospital, University of Toronto  - Clinical Research  Fellow

Dr Konstantinos Tselios

MD, PhD

Toronto Western Hospital, University of Toronto

Clinical Research Fellow

Toronto, Ontario | Canada

Additional Specialties: Rheumatology

Dr Konstantinos Tselios, MD, PhD - Toronto Western Hospital, University of Toronto  - Clinical Research  Fellow

Dr Konstantinos Tselios

MD, PhD

Introduction

Primary Affiliation: Toronto Western Hospital, University of Toronto - Toronto, Ontario , Canada

Additional Specialties:

Research Interests:

Publications

32Publications

645Reads

-Profile Views

43PubMed Central Citations

How can we define low disease activity in systemic lupus erythematosus?

Semin Arthritis Rheum 2019 Jun 16;48(6):1035-1040. Epub 2018 Oct 16.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00490172183048
Publisher Site
http://dx.doi.org/10.1016/j.semarthrit.2018.10.013DOI Listing
June 2019
27 Reads
3.925 Impact Factor

Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.

Arthritis Care Res (Hoboken) 2019 Jun 10;71(6):822-828. Epub 2019 May 10.

University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23720DOI Listing
June 2019
1 Read
4.713 Impact Factor

Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?

J Rheumatol 2019 Apr 15;46(4):391-396. Epub 2018 Oct 15.

From the University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network; University of Toronto, Krembil Research Institute; Department of Cardiology, University of Toronto, Women's College Hospital; Mecklinger Family and Posluns Family Cardiac Catheterization Research Laboratory, Department of Medicine, Division of Cardiology, Mount Sinai Hospital, University of Toronto; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180124DOI Listing
April 2019
38 Reads
3.190 Impact Factor

Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?

J Rheumatol 2019 Jan 1;46(1):64-69. Epub 2018 Aug 1.

From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171436DOI Listing
January 2019
13 Reads
3.190 Impact Factor

Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience.

Clin Rheumatol 2019 01;38(1):269

Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital, University of Toronto Lupus Clinic, University Health Network, 399 Bathurst St. 1E-410B, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-018-4363-0DOI Listing
January 2019
9 Reads
1.774 Impact Factor

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

J Rheumatol 2018 Oct 1;45(10):1426-1439. Epub 2018 Sep 1.

From the Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Canadian Arthritis Patient Alliance; Division of Rheumatology, Department of Medicine, McGill University; Division of Rheumatology, Department of Medicine, Université de Montréal, Montreal; Division of Rheumatology, Department of Medicine, Université Laval, Quebec City, Quebec; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario; Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; Division of Rheumatology, Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario; Division of Rheumatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba; General Internal Medicine, McGill University Health Centre, McGill University, Montreal, Quebec; Cochrane Musculoskeletal Group, University of Ottawa, Ottawa; Division of Rheumatology, Department of Medicine, Western University, London, Ontario; Canadian Agency for Drugs and Technologies in Health, Ottawa; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton; Centre for Practice-changing Research, Ottawa Hospital Research Institute, Ottawa, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171459DOI Listing
October 2018
30 Reads
3.190 Impact Factor

Monophasic Disease Course in Systemic Lupus Erythematosus.

J Rheumatol 2018 Aug 1;45(8):1131-1135. Epub 2018 Jun 1.

From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171319DOI Listing
August 2018
13 Reads
3.190 Impact Factor

Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis.

J Clin Rheumatol 2018 Mar;24(2):93-94

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000600DOI Listing
March 2018
2 Reads
1.250 Impact Factor

Psoriasis in systemic lupus erythematosus: a single-center experience.

Clin Rheumatol 2017 Apr 6;36(4):879-884. Epub 2017 Feb 6.

Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital, University of Toronto Lupus Clinic, University Health Network, 399 Bathurst St. 1E-410B, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-017-3566-0DOI Listing
April 2017
74 Reads
2 Citations
1.774 Impact Factor

Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus.

Rheumatol Int 2017 Feb 21;37(2):293-298. Epub 2016 Nov 21.

Clinical Immunology Unit, Second Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloníki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-016-3610-4DOI Listing
February 2017
24 Reads
1.630 Impact Factor

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies.

Open Access Rheumatol 2017 20;9:1-9. Epub 2016 Dec 20.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OARRR.S123549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191623PMC
December 2016
17 Reads
1 Citation

Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study.

Arthritis Care Res (Hoboken) 2016 10 19;68(10):1497-504. Epub 2016 Aug 19.

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22857DOI Listing
October 2016
16 Reads
1 Citation
4.713 Impact Factor

Dr. Tselios, et al reply.

J Rheumatol 2016 09;43(9):1767

Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160749DOI Listing
September 2016
11 Reads
3.190 Impact Factor

Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.

J Clin Rheumatol 2016 Aug;22(5):287-8

University of Toronto Lupus Clinic Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital Toronto, Ontario, Canada Department of Medicine University of Toronto and Department of Medicine Women's College Hospital Toronto, Ontario, Canada Mecklinger Family and Posluns Family Cardiac Catheterization Research Laboratory Department of Medicine Division of Cardiology Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada Fred A. Litwin Family Centre in Genetic Medicine Department of Medicine Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada University Health Network Pathology Department Toronto General Research Institute Toronto, Ontario, Canada University of Toronto Lupus Clinic Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000400DOI Listing
August 2016
36 Reads
1 Citation
1.250 Impact Factor

Dyslipidemia in systemic lupus erythematosus: just another comorbidity?

Semin Arthritis Rheum 2016 Apr 29;45(5):604-10. Epub 2015 Oct 29.

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2015.10.010DOI Listing
April 2016
37 Reads
11 Citations
3.925 Impact Factor

Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.

J Rheumatol 2016 Mar 15;43(3):552-8. Epub 2016 Jan 15.

From the Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FCRPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; J. Su, MB, BSc, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150779DOI Listing
March 2016
78 Reads
3.190 Impact Factor

Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.

J Rheumatol 2016 Jan 15;43(1):54-65. Epub 2015 Nov 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.K. Tselios, MD, PhD, Clinical Research Fellow, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital; B.J. Sheane, MD, MB, BSc, BAO, Clinical Research Fellow, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital; D.D. Gladman, MD, FRCPC, Professor of Medicine, Senior Scientist, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital; M.B. Urowitz, MD, FRCPC, Professor of Medicine, Senior Scientist, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150460DOI Listing
January 2016
43 Reads
8 Citations
3.190 Impact Factor

T regulatory cells: a promising new target in atherosclerosis.

Crit Rev Immunol 2014 ;34(5):389-97

Clinical Immunology Unit, 2nd Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Greece.

View Article

Download full-text PDF

Source
July 2015
4 Reads
1 Citation
3.700 Impact Factor

CD4+CD25highFOXP3+ T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study.

Clin Exp Rheumatol 2014 Sep-Oct;32(5):630-9. Epub 2014 Sep 8.

Clinical Immunology Unit, 2nd Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Greece.

View Article

Download full-text PDF

Source
December 2014
3 Reads
2 Citations
2.724 Impact Factor

Systemic sclerosis and silicone breast implant: a case report and review of the literature.

Case Rep Rheumatol 2014 30;2014:809629. Epub 2014 Sep 30.

Clinical Immunology Unit, 2nd Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos Street 49, 546 42 Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/809629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199071PMC
October 2014
4 Reads

Tocilizumab treatment leads to a rapid and sustained increase in Treg cell levels in rheumatoid arthritis patients: comment on the article by Thiolat et al.

Arthritis Rheumatol 2014 Sep;66(9):2638

Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.38714DOI Listing
September 2014
32 Reads
3 Citations

Increase of peripheral T regulatory cells during remission induction with cyclophosphamide in active systemic lupus erythematosus.

Int J Rheum Dis 2014 Sep;17(7):790-5

Clinical Immunology Unit, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1756-185X.12500DOI Listing
September 2014
9 Reads
1 Citation
1.771 Impact Factor

Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal.

Semin Arthritis Rheum 2014 Feb 15;43(4):521-5. Epub 2013 Aug 15.

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2013.07.007DOI Listing
February 2014
34 Reads
2 Citations
3.925 Impact Factor

Fatal refractory thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus.

J Clin Rheumatol 2013 Oct;19(7):412-4

From the Clinical Immunology Unit, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0b013e3182a703bfDOI Listing
October 2013
8 Reads
1 Citation
1.250 Impact Factor

The role of anti-phosphatidylserine/prothrombin antibodies in thrombotic manifestations of systemic lupus erythematosus patients.

Front Neurol 2013 4;4:66. Epub 2013 Jun 4.

Clinical Immunology Unit, Second Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2013.00066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671346PMC
June 2013
49 Reads

Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.

BMC Infect Dis 2011 Dec 29;11:358. Epub 2011 Dec 29.

Clinical Immunology Unit, 2nd Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2334-11-358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265447PMC
December 2011
6 Reads
2 Citations
2.613 Impact Factor

Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs.

Clin Dev Immunol 2008 25;2008:327346. Epub 2009 Jan 25.

Clinical Immunology Unit, 2nd Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos Street 49, 546 42 Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2008/327346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630417PMC
March 2009
7 Reads
3 Citations
2.934 Impact Factor

Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature.

Clin Rheumatol 2008 Nov 29;27(11):1459-61. Epub 2008 Jul 29.

Thalassemic Unit, Hippokration General Hospital, Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-008-0969-yDOI Listing
November 2008
5 Reads
1.774 Impact Factor

Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report.

Int J Hematol 2008 Oct 3;88(3):341-342. Epub 2008 Sep 3.

Hematology Unit, 2nd Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos St. 49, 54642, Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-008-0158-4DOI Listing
October 2008
3 Reads
1 Citation
1.680 Impact Factor

Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case.

Clin Rheumatol 2005 Aug 24;24(4):420-4. Epub 2005 May 24.

Internal Medicine and Clinical Immunology, 2nd Department of Internal Medicine, Hippokration General Hospital, Aristotelian University of Thessaloniki, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-004-1062-9DOI Listing
August 2005
4 Reads
2 Citations
1.774 Impact Factor

Antiphospholipid syndrome in Greece: clinical and immunological study and review of the literature.

Angiology 2004 Jul-Aug;55(4):421-30

Outpatient Clinic, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration Hospital, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/000331970405500409DOI Listing
September 2004
3 Reads
2.370 Impact Factor

Top co-authors

Dafna D Gladman
Dafna D Gladman

University of Toronto

17
Murray B Urowitz
Murray B Urowitz

Toronto Western Hospital

16
Panagiota Boura
Panagiota Boura

Aristotle University Thessaloniki

13
Alexandros Sarantopoulos
Alexandros Sarantopoulos

Hippokration General Hospital

11
Jiandong Su
Jiandong Su

University of Toronto

8
Ioannis Gkougkourelas
Ioannis Gkougkourelas

Clinical Immunology Unit

8
Zahi Touma
Zahi Touma

Toronto Western Hospital/ University of Toronto

3
Panagiotis Skendros
Panagiotis Skendros

Democritus University of Thrace

3
Paula Harvey
Paula Harvey

University of Toronto

3
Kristy Su-Ying Yap
Kristy Su-Ying Yap

Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital

2